Peripheral Vascular Care: What is
Emerging Opportunity?Peripheral vascular disease (PVD) care has become a hot topic in hospital and medical circles over
past few years. The attention
topic has been receiving is analogous to
famous line in
movie, The Graduate when
star was given advice to go to work in “plastics” to ensure career success. As with “plastics,” PVD care has not taken off as expected. A number of factors have influenced
development—or lack of development—with
greatest being PVD’s “big sister,” coronary artery disease, claiming most of
healthcare attention, to say nothing about its appetite for resources.
Should your hospital or health system focus on and commit resources to enhance PVD services? What is
market opportunity? What is
revenue potential? What does a “best” program look like? Spending time doing research and working through these questions will take
guesswork out of identifying
emerging opportunity for peripheral vascular care for your organization.
What is PVD?
PVD is a condition in which
arteries that carry blood throughout
body become narrowed or clogged. This interferes with
normal flow of blood and can cause pain and physical limitations. Conditions affecting
arteries of
heart are considered Coronary Artery Disease (CAD).
One of
most significant risk factors for PVD is age. The older population is projected to double over
next 30 years, reaching 70 million by 2030. A national study: PAD Awareness, Risk and Treatment—New Resources for Survival (PARTNERS published in
Journal of
American Medical Association (JAMA September 19, 2001) found that PVD is seriously under-diagnosed and under-treated. The American Heart Association and Harvard Health estimate: •300,000 PVD cases are diagnosed each year. •Eight to 10 million Americans are affected. •PVD is two to five times more common in men. •PVD patients have a six-fold higher death rate from cardiovascular disease. •PVD patients have a 15 percent chance of dying within five years when symptomatic. •PVD patients have a 50 percent chance of dying within 10 years from PVD.
Who Treats PVD?
Treatment for PVD can follow three main pathways:
•Noninvasive disease management that includes risk-factor reduction, medications to relieve symptoms and increase exercise tolerance and gene-based therapy. •Surgical intervention that is safe and effective for many patients in whom less invasive procedures are not adequate. •Catheter-based treatments that have an important and increasing role in
treatment of PVD.
Primary Care Physicians are often
first provider to identify
problem. Cardiologists may identify PVD during cardiac catheterization procedures.
The more complicated issue related to PVD is which specialist should provide treatment. Traditionally, interventional radiologists and vascular surgeons have treated patients with advanced stage PVD. With
introduction of catheter-based interventions, cardiologists are treating PVD in
catheterization lab. This shift has set
stage for cultural and political “turf wars” that need to be addressed and resolved if a hospital is to have a full service, integrated program.
What Are
Costs and Revenue Associated with PVD Care?